ROCKET PHARMACEUTICALS, INC. (RCKT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$7.70M2015: -$20.40M2016: -$7.57M2017: -$19.77M2018: -$71.16M2019: -$76.15M2020: -$134.30M2021: -$167.25M2022: -$224.34M2023: -$259.66M2024: -$273.20M2025: -$231.75M-$231.75M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$231.75M+15.2%
2024-$273.20M-5.2%
2023-$259.66M-15.7%
2022-$224.34M-34.1%
2021-$167.25M-24.5%
2020-$134.30M-76.4%
2019-$76.15M-7.0%
2018-$71.16M-259.9%
2017-$19.77M-161.1%
2016-$7.57M+62.9%
2015-$20.40M-164.7%
2014-$7.70M